Author Archives: Megan Thomas

#Clinical trials #Decentralised clinical trials #Digitalisation

Cambridge Cognition set to become key player in virtual clinical trials 

Cambridge Cognition has entered into an agreement to acquire eClinicalHealth Ltd (eCH), a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies.   Catalysed by the pandemic, the overall virtual clinical trials market has grown rapidly… Read More

#News

#Comment #Drug Discovery 2022 #ELRIG #Events

Reflecting on ELRIG’s Drug Discovery 2022 

The DDW team spent 4-5 October, 2022 at ELRIG’s annual meeting, Drug Discovery 2022, which remains Europe’s largest meeting for life sciences industry professionals and took place at ExCel, London, UK. DDW’s Megan Thomas comments on the presentations, posters and booths at the event and the new addition of the… Read More

#Exclusive Content #Opinion

#AI #Biopharmaceuticals #Collaboration #Neuroscience #Psychiatry #Therapeutics

Collaboration extended in severe neuropsychiatric disorders 

Clinical-stage biopharmaceutical company Karuna Therapeutics has extended its drug discovery collaboration with PsychoGenics, AI-enabled phenotypic drug discovery and preclinical CRO services.  The collaboration aims to identify potential novel drug candidates for the treatment of severe neuropsychiatric disorders.  The initial multi-year agreement, announced in July 2020,… Read More

#News

#Biotechnology #Data #Immunology / Virology & Vaccines #In Silico Biology

Sekkei Bio implements system to centralise research data 

Sekkei Bio, an India-based company dedicated to building technologies for drug and vaccine design with global impact, has implemented CDD Vault as the main platform to house its research data.   Sekkei Bio has made progress toward finding therapies for diabetes and pain, and has a management team… Read More

#News

#cryo-microscopy #Drug discovery #Webinar

Utilising novel sample preparation techniques to enhance Cryo-EM structural analysis 

Cryo-EM has been adopted into drug discovery workflows by the pharmaceutical and biotechnology industries having proved itself capable of delivering atomic resolution structures for key targets, including integral membrane proteins such as GPCRs and ion channels.   More recently, significant improvements in throughput have seen use of the… Read More

Webinar date:
Brought to you by SPT LabTech
#Webinars

#Biosciences #Funding #Liver disease #Phenotyping

$30 million financing for RNA therapies for chronic liver diseases 

Ochre Bio, a company developing therapies for liver health challenges, has closed $30 million in Series A financing, which will be used to translate the insights from their discovery research into RNA-based drug candidates, and then test these in human livers at their recently launched ‘Liver ICUs’ across the… Read More

#News

DDW introduces round-up podcast  

The first episode of the DDW Highlights podcast is now available for download. In an increasingly busy world, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This round-up was compiled by DDW’s Diana Spencer… Read More

#News

#DDW Highlights podcast

DDW Highlights: 10 October 2022

The first episode of the DDW Highlights podcast is now available for download. In an increasingly busy world, DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This round-up was compiled by DDW’s Diana Spencer… Read More

#Podcasts

#Drug discovery #Peptides #Reagents #Video

Video: Where chemistry meets biology and products meet services

Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. Biosynth manufacture and source a vast range of chemical and biochemical products and provide a full range of products… Read More

#News

#Electronic Lab Notebooks (ELN) #Lab analytics

Whitepaper: Read the Top Five Benefits of a Cloud ELN

As experimental data becomes bigger and more complex, scientists are challenged to make discoveries faster, consistently document and analyse their work, and easily collaborate across an organisation and with external partners. Electronic lab notebooks (ELN) provide access to all collaborators 24/7, wherever they are and whether they are employees or… Read More

#News

#Automation / robotics #Drug Discovery 2022 #ELRIG #Events #Lab automation

Tech Theatre ELRIG 2022: First steps towards liquid handling automation

Join Anne Hammerstein, Ph.D., Product Manager at SPT Labtech, for a fascinating deep dive into the practical considerations of how, when and why you should automate your laboratory’s liquid handling processes. The talk will take place at ELRIG’s Drug Discovery 2022 Tech Theatre, supported by DDW. The event will take… Read More

#News

#Immunology #In vivo #Mouse models #T-Cells

Read the Top Five Benefits of a Cloud ELN

As experimental data becomes bigger and more complex, scientists are challenged to make discoveries faster, consistently document and analyse their work, and easily collaborate across an organisation and with external partners. Electronic lab notebooks (ELN) provide access to all collaborators 24/7, wherever they are and whether they are employees or… Read More

#Intelligence #Resources

#Automation / robotics #Biotechnology #Drug discovery #Drug screening #ELRIG #Events #Life sciences

Comment: Join the science revolution at Drug Discovery 2022 

ELRIG CEO Sanj Kumar tells readers how they can access the most exciting research and find the latest technologies to propel their projects forward at this year’s Drug Discovery 2022  At ELRIG, our purpose is to support researchers in the life sciences and drug discovery communities to learn, share, innovate,… Read More

#Exclusive Content #Opinion

Cancer cells
#Cancer research #mRNA #Wellcome Sanger Institute

Study develops new way of identifying cancer cells  

A new method of separating cancer cells from non-cancer cells has been developed by researchers at the Wellcome Sanger Institute, in a boost for those working to better understand cancer biology using single-cell mRNA sequencing.  The study, published in Communications Biology, improves on existing methods to identify… Read More

#Cancer Research #News

#Clinical development #Immunology / Virology & Vaccines #Infectious diseases #mRNA #Public health

mRNA technology may hold the future for a cytomegalovirus vaccine 

Listen to this article on the DDW podcast: Allison August, M.D., Vice President, Clinical Development, Infectious Diseases at Moderna examines the data on cytomegalovirus (CMV), why attempts at vaccines for CMV have so far proved elusive and the emerging options to address this unmet need.  Although cytomegalovirus (CMV) is almost… Read More

#Exclusive Content #Trends & Analysis